Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1601 | Thyroid (non-cancer) | ICEECE2012

The effect of radioiodine therapy in 950 patients with subclinical hyperthyroidism

Abdelrazek S. , Rogowski F. , Szelachowska M. , Mojsak M. , Kraszynska A. , Kornas M. , Gorska M.

The aim of our study was to assess the influence of radioiodine (131I) therapy on the achievement of euthyroidism, prevention of adverse effects on the cardiovascular and prevent evolvement to overt hyperthyroidism. Material and methods: We treated 950 patients, aged 30–70 years; 87% of them were female and 13% male; 320 patients with multinodular goitre (MNG), and 630 patients with autonomous nodule (ATN). Some of the patients were treated with antithyroid drugs for 1 to...

ea0029p1647 | Thyroid (non-cancer) | ICEECE2012

The outcome of radioiodine therapy after five years in patient with non-toxic nodular goitre

Abdelrazek S. , Rogowski F. , Szumowski P. , Mojsak M. , Zonenberg A. , Siewko K.

The aim of our study was to evaluate the short term efficacy of radioiodine therapy (RIT) to reduce thyroid volume with minimal risk of hypothyroidism in patients with non-toxic nodular goitre. Material and Methods: We treated 120 patients, aged 20–76 years; (88%) of the studied groups were female and (12%) male. Initial 24 h RAIU was ranged between 22–44% and effective half-life was more than 3 days. Thyroid volume ranged between 42–170 ml. Malignant changes we...